Send the following on WhatsApp
Continue to ChatAwakn Life Sciences Signs Drug Development Agreement with Catalent for Zydis(R) Technology to Conduct Feasibility Studies to Improve Differentiation of Its MDMA Program https://www.nxtpsychedelics.com/news/articles/psychedelics/awakn-life-sciences-signs-drug-development-agreement-with-catalent-for-zydisr-technology-to-conduct-feasibility-studies-to-improve-differentiation-of-its-mdma-program/